Tango Therapeutics, Inc.

Tango Therapeutics, Inc. - PE Ratioverified

TNGX

Price:

$27.97

Market Cap:

$3.48B

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., foc...[Read more]

Industry

Biotechnology

IPO Date

2020-09-03

Stock Exchange

NASDAQ

Ticker

TNGX

The PE Ratio as of June 2026 (TTM) for Tango Therapeutics, Inc. (TNGX) is -33.70

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -33.70. This represents a change of 988.48% compared to the average of -3.10 of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical PE Ratio (quarterly & annually)

How has TNGX PE Ratio performed in the past?

The mean historical PE Ratio of Tango Therapeutics, Inc. over the last ten years is -7.58. The current -33.70 PE Ratio has changed 44.36% with respect to the historical average. Over the past ten years (40 quarters), TNGX's PE Ratio was at its highest in in the September 2025 quarter at 15.00. The PE Ratio was at its lowest in in the September 2020 quarter at -1079.17.

Quarterly (TTM)
Annual

Average

-7.58

Median

-7.06

Minimum

-11.64

Maximum

-2.60

Tango Therapeutics, Inc. (TNGX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 292.20%

Maximum Annual PE Ratio = -2.60

Minimum Annual Increase = -71.67%

Minimum Annual PE Ratio = -11.64

Quarterly (TTM)
Annual
YearPE RatioChange
2025-10.18292.20%
2024-2.60-71.67%
2023-9.1755.52%
2022-5.89-49.35%
2021-11.6464.81%
2020-7.068.38%

Tango Therapeutics, Inc. (TNGX) Average PE Ratio

How has TNGX PE Ratio performed in the past?

The current PE Ratio of Tango Therapeutics, Inc. (TNGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-7.32

5-year avg

-7.90

10-year avg

-7.58

Tango Therapeutics, Inc. (TNGX) PE Ratio vs. Peers

How is TNGX’s PE Ratio compared to its peers?

Tango Therapeutics, Inc.’s PE Ratio is greater than Septerna, Inc. (-44.65), less than UroGen Pharma Ltd. (-12.21), less than ProKidney Corp. (-3.33), less than EyePoint Pharmaceuticals, Inc. (-3.88), less than Bicara Therapeutics Inc. Common Stock (-8.36), less than Kodiak Sciences Inc. (-8.67), less than Kura Oncology, Inc. (-2.96), less than Nurix Therapeutics, Inc. (-5.55), less than Xencor, Inc. (-5.52), less than Fortrea Holdings Inc. (-3.11),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Tango Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Tango Therapeutics, Inc. (TNGX)?

What is the highest PE Ratio for Tango Therapeutics, Inc. (TNGX)?

What is the 3-year average PE Ratio for Tango Therapeutics, Inc. (TNGX)?

What is the 5-year average PE Ratio for Tango Therapeutics, Inc. (TNGX)?

How does the current PE Ratio for Tango Therapeutics, Inc. (TNGX) compare to its historical average?